CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 16,900	$ 18,318
Restricted cash	60	60
Short-term investments in debt and other securities	3,493	8,966
Accounts receivable, net	5,809	8,893
Other current assets	1,207	1,198
Total current assets	27,469	37,435
Investments in debt securities	2,959	0
Investments in equity method investees	3,698	3,668
Property and equipment, net	371	404
Content assets, net	31,311	31,000
Operating lease right-of-use assets	2,684	2,763
Other assets	664	461
Total assets	69,156	75,731
Current liabilities
Content liabilities	306	362
Accounts payable	6,415	9,449
Accrued expenses and other liabilities	13,455	12,094
Deferred revenue	8,618	8,409
Total current liabilities	28,794	30,314
Non-current operating lease liabilities	3,347	3,460
Other liabilities	554	470
Total liabilities	32,695	34,244
Commitments and contingencies (Note 13)
Stockholders’ equity
Common stock, $0.0001 par value – 125,000 shares authorized as of March 31, 2026, and December 31, 2025; 59,593 and 58,950 issued, including 306 and 216 treasury shares; 59,288 and 58,734 shares outstanding as of March 31, 2026, and December 31, 2025, respectively.	5	5
Treasury stock	(562)	(251)
Additional paid-in capital	379,136	377,577
Accumulated deficit	(342,118)	(335,844)
Total stockholders’ equity	36,461	41,487
Total liabilities and stockholders’ equity	$ 69,156	$ 75,731